Skip to: Content
Skip to: Site Navigation
Skip to: Search

May 17, 2008 12:05:02 AM CDT

Learn about Newser Points »

Back to the grid

FDA Delay Cost 22,000 Lives: Doctor  

Posted Feb 15, 08 7:53 AM CST in Science & Health    Most Covered

(newser) – A prominent researcher who revealed widespread fatalities associated with the heart surgery drug Trasylol says 22,000 people died because of the FDA's delay in blowing the whistle on the drug after his study was published. Drugmaker Bayer also failed to disclose negative results of its own study. In a 60 Minutes interview to air Sunday, Dr. Dennis Mangano says the FDA waited more than a year to pull Trasylol—until after it was banned in Germany.

Mangano's study associated the drug, used to limit bleeding in heart surgery, with kidney failure. In September 2006, when Mangano presented his study to the FDA, Bayer defended the product. and failed to disclose the company's own earlier research, which confirmed Mangano's results. The FDA finally halted sales of Trasylol in November 2007.

Source CBS

open commentscomments (0)

Editor Recommended

Bayer faces Trasylol lawsuits
Reuters | Feb 14, 08

In some studies, Trasylol shown to be safe
Bloomberg | Feb 8, 08

Related News

  • Sales of Heart-Surgery Drug Halted

    Nov 5, 07 9:35 PM CST
    Sales of Heart-Surgery Drug Halted Bayer Pharmaceuticals will suspend the sale of Trasylol, a drug used to control bleeding during heart bypass surgery, after a clinical study found that the drug puts patients at increased risk of death, the Washington Post reports. The FDA said sales of the drug would be halted at least until the agency had reviewed the study. More »

FDA Delay Cost 22,000 Lives: Doctor
The logo of pharmaceutical giant Bayer, manufacturer of Trasylol   (Getty Images)
FDA Delay Cost 22,000 Lives: Doctor
A bottle of the drug Trasylol by German pharma company Bayer is seen in a hospital in Dusseldorf, western Germany, Feb. 7, 2007. Drug maker Bayer AG said Monday, Nov. 5, 2007, that it has halted the global...   (Associated Press)
FDA Delay Cost 22,000 Lives: Doctor
A bottle of the drug Trasylol by German pharma company Bayer is seen in a hospital in Dusseldorf, western Germany, Feb. 7, 2007. Drug maker Bayer AG said Monday, Nov. 5, 2007, that it has halted the global...   (Associated Press)
FDA Delay Cost 22,000 Lives: Doctor
CEO of German pharmaceutical giant Bayer Werner Wenning addresses a third-quarter results press conference in Leverkusen 06 November 2007. German chemicals and pharmaceutical group Bayer posted a third...   (Getty Images)
prev   next
play

Threads (1 of 3)

Tags

FDA  • pharmaceutical companies  • heart surgery  • Trasylol  • Bayer Pharmaceuticals  • kidney failure


Loading...

Loading...

Related Threads: Pharma Misbehaving, Heart Health, Angioplasty

Next story from this section »

Today's Most Popular

Loading...

Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »